DAIRYNCT06694155
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
At risk: Primary completion moved at least 3 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 21 words Show 5 more changesShow less
- Primary completion pushed from Nov 1, 2026 to Feb 28, 2027
- Study completion pushed from Mar 1, 2027 to Dec 31, 2027
- Secondary endpoints: details revised at 1 of 2 entries
- Site contact updated
- Study description expanded, about 3 words
- Notable Eligibility criteria expanded, about 11 words
- Study completion date: Nov 1, 2026 to Mar 1, 2027
- Minor Site contact updatedv4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Dec 1, 2024 to Jan 15, 2025
- Site details revised
- Minor Interventions: Whey Protein Isolate Crossover (Dietary Supplement) to Placebo (Dietary Supplement), Whey Protein Isolate Crossover (Dietary Supplement)
- Secondary endpoints: details revised at 1 of 2 entries
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Whole body protein turnover
Timeframe: 7 days
Oral Glucose Tolerance Test
Timeframe: 7 days
Blood glucose
Timeframe: 7 days
Secondary (2)
Composite Appetite Scale
Dietary Intake Log
Arms and interventions
Whey Protein SupplementationExperimental
Crossover study
Placebo SupplementationPlacebo comparator
Crossover study
Dietary supplements: Whey Protein Isolate Crossover, Placebo
Sites
1 site in 1 country
- University of Arkansas for Medical SciencesLittle Rock, Arkansas, United States